載入...
Trial Watch: Chemotherapy with immunogenic cell death inducers
Accumulating evidence suggests that the clinical efficacy of selected anticancer drugs, including conventional chemotherapeutics as well as targeted anticancer agents, originates (at least in part) from their ability to elicit a novel or reinstate a pre-existing tumor-specific immune response. One o...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Landes Bioscience
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4008470/ https://ncbi.nlm.nih.gov/pubmed/24800173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27878 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|